FDA Clears AI-Enabled Ultrasound for High-Volume Clinical Settings

The Food and Drug Administration has issued 510(k) clearance for the Alturion ultrasound system, an AI-powered platform that may improve efficiencies in high-volume clinical settings.

Emphasizing clear visualization and portability, the Alturion ultrasound system combines an expansive 24-inch monitor with a device design that facilitates ease of maneuverability, according to Philips, the manufacturer of the device.

The company said the Alturion ultrasound system also features the recently FDA-cleared Elevate Plus software, which offers AI-enabled measurements for abdominal ultrasound views, and compatibility with Collaboration Live, which enables multiple clinicians to have real-time remote support and consultation. The Alturion ultrasound system also has interchangeable transducers that are compatible with the Philips EPIQ Elite and Affiniti ultrasound systems, according to Philips.

“At Philips, our goal is to develop technology that adapts to the realities of modern health care and helps care teams work more effectively in increasingly demanding clinical environments,” said Jie Xue, the chief business leader for precision diagnosis at Philips. “Alturion was designed with that goal in mind, helping healthcare providers deliver high-quality care with greater efficiency and confidence.”